Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy

Context: The treatment of neurogenic diabetes insipidus (DI) in infancy is challenging and complicated by fluid overload and dehydration. Therapy with subcutaneous (SC), intranasal (IN), or oral tablet desmopressin acetate (1-desamino-8-D-arginine vasopressin [DDAVP]) remains difficult to titrate in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2016-05, Vol.101 (5), p.2084-2088
Hauptverfasser:	Smego, Allison R, Backeljauw, Philippe, Gutmark-Little, Iris
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Buccal Administration, Intranasal Antidiuretic Agents - administration & dosage Antidiuretic Agents - therapeutic use Deamino Arginine Vasopressin - administration & dosage Deamino Arginine Vasopressin - therapeutic use Diabetes Insipidus, Neurogenic - drug therapy Female Humans Infant Infant, Newborn Male Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!